# A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:

Study · id `cardio:ct-nct06676072` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06676072](<https://clinicaltrials.gov/study/NCT06676072>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06676072

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 188 participants.

## Technical summary

Registry record NCT06676072. Allocation not applicable; no masking; primary purpose treatment. Start 2024-11-22 (actual); primary completion 2026-04-13 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 188 participants (enrolled count; ClinicalTrials.gov record NCT06676072, source copy `cardio:ctgov-nct06676072-2026-06-01`, retrieved 2026-10-26)
- Started: 2024-11-22 (actual) (ClinicalTrials.gov record NCT06676072, source copy `cardio:ctgov-nct06676072-2026-06-01`, retrieved 2026-10-26)
- Primary completion: 2026-04-13 (actual) (ClinicalTrials.gov record NCT06676072, source copy `cardio:ctgov-nct06676072-2026-06-01`, retrieved 2026-10-26)
- Completion: 2026-04-13 (actual) (ClinicalTrials.gov record NCT06676072, source copy `cardio:ctgov-nct06676072-2026-06-01`, retrieved 2026-10-26)
- Countries: United States; Austria; Lithuania; Netherlands (ClinicalTrials.gov record NCT06676072, source copy `cardio:ctgov-nct06676072-2026-06-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06676072-2026-06-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:
- Acronym: FlexPulse IDE
- Condition: Atrial Fibrillation (AF)
- Condition: Atrial Arrhythmia
- Condition: Paroxysmal AF
- Condition: Drug Refractory Paroxysmal Atrial Fibrillation
- Intervention (Device): PFA Ablation catheter
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: 859ad9ed5b6faa89d84bc39c3e30469676ab2ee325a58b77e7119c530182f876
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
